Difficult-to-treat
The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult to treat non tuberculous mycobacterial lung diseases
... Recently, liposomal amikacin for inhalation (LAI) has been developed [22]. A phase 2 study, investigat- ing the efficacy and safety of 590 mg/day of LAI for pulmonary nontuberculous mycobacterial disease that was ...
9
Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab
... and difficult-to-treat ulcerative colitis patients, adalimumab was shown to be effective at inducing and maintaining a durable clinical remission and to have a steroid-sparing ...
8
Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey
... of difficult-to-treat RA: disease activity level; presence of fatigue; number of DMARDs that failed; inability to taper glucocorticoid (GC) ...for difficult-to-treat RA’; ‘Please mention ...
15
Novel drugs in the management of difficult-to-treat hepatitis C genotypes
... Background: Hepatitis C virus (HCV) infection is the most common chronic bloodborne infection in the United States, with approximately 3.2 million Americans being chronically infected. Rates of HCV-related end-stage ...
9
Difficult to Treat Depression and GPs’ Role: Perceptions of Psychologists
... of difficult to treat de- pression (DTTD) and b) explore what they thought about the GPs’ role in managing these patient given that most patients are referred to psychologist by ...be difficult ...
9
Treatment options for refractory and difficult to treat seizures: focus on vigabatrin
... Abstract: Complex partial seizures are often refractory to current pharmacological therapies. These difficult to treat seizures are typically managed using multiple antiepileptic drugs (AEDs). AEDs as a ...
9
Value of Child Turcotte Pugh Score in Prediction of Treatment Response in “Difficult to Treat” Chronic HCV Cirrhotic Patients
... to treat” ...to treat” chronic HCV ...to treat” patients were randomly selected from the follow-up ...to treat” chronic HCV patients, but it is significantly associated with the occurrence of ...
12
Difficult to Treat Depression—Perceptions of GPs and GP Trainees
... Introduction: GPs are often the first contact point for mental health concerns. Training to qualify as a GP involves completing a three-to-four year program. Among other things, the training pro- gram may include a ...
11
Interprofessional Communication and Relationships in the Management of “Difficult to Treat” Depression: Perceptions of the Role of General Practitioners
... Findings: Four main themes emerged: 1 The team approach was important, particularly to ensure information accuracy and/or when responding to patient needs and pressures; 2 Referrals, usu[r] ...
7
Cannabinoids in the management of difficult to treat pain
... Similarly, while Sativex and smoked cannabis have not been employed in the same clinical trial, comparisons of side effect profi les can be made on the basis of SAFEX studies of Sative[r] ...
16
Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients
... Thirty-one depressed outpatients (16 unipolar and 15 bipolar without seasonal pattern) were enrolled in the study. A total of 110 outpatients referred for the treatment of depressive [r] ...
8
Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma
... Stem cell transplant and pralatrexate therapy: outcome of patients with relapsed or refrac- tory peripheral T-cell lymphoma who received SCT prior to or fol- lowing [r] ...
8
HCV infected prisoners: should they be still considered a difficult to treat population?
... Despite the promising scenario of future therapies, HCV infected inmates will remain for many years a hard to reach and hard to treat population. Therefore, public health and correctional institutions should ...
7
Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline
... cIAIs and cSSSIs can be very challenging to manage and treat. These infections vary greatly in severity based not only on general patients’ health (immunosuppression, comorbidities, etc) but also on the wide ...
12
Difficult-to-treat-pediatric Crohn's disease: focus on adalimumab
... to treat pediatric CD, regulatory approval was secured many years following approval for ...for treat- ment of CD is limited, and pediatric practitioners have mostly extrapolated from research and ...
8
Clinical outcome of Neonatal Seizures
... Thus early onset seizures, seizures difficult to treat, abnormal neurological examination, abnormal ultrasonography, presence of comorbidities like shock, mixed and tonic seizures and id[r] ...
96
MOLECULAR DETECTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) IN CLINICAL ISOLATES FROM MAITAMA DISTRICT HOSPITAL, ABUJA, NIGERIA
... causing difficult- to treat infections in hospital and community setting due to its multidrug resistance to β-lactam antibiotics, posing a significant limitation on the treatment of diseases caused by ...
6
Pain Management in Spinal Cord Injury: A Narrative Review
... are difficult to treat with morphine alone, therefore the trials were done to examine a combination of morphine and other drugs like clonidine and confirmed their efficacy in relieving pain ...
7
SYSTEMIC LUPUS ERYTHEMATOSUS
... Systemic Lupus Erythematosus is autoimmune and a complicated disease which is very difficult to treat and diagnose. The exact cause / Aetiology of abnormal autoantibody production and development of SLE is ...
5
Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties
... The main purpose of the ODO formulation has not been to alter the active ingredient but rather to enhance its palat- ability, ease of ingestion, convenience, and acceptability in patients, particularly those ...
17